ATLAS fair value
CHF 38.27
Above fair value · 118% premium
Bachem stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · SIX Swiss Exchange · Switzerland
Prices as of Oct 27, 2026 · CHF
CHF 38.27
Above fair value · 118% premium
51%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS estimates Bachem's fair value at about CHF 38.27 per share (reasonable range: CHF 25.73 to CHF 56.37). At CHF 83.35, the stock trades 118% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Bachem a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between CHF 79.38 and CHF 87.90; in 9 out of 10, between CHF 72.52 and CHF 96.22. Estimated annual volatility is 26%.
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Bachem sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks BANB.SW has traded between CHF 48.52 and CHF 86.00. Today it is 3.1% below that high and 72% above its low.
On the business: net margin is 21.0%; it trades at 42.5 times earnings.
Its beta is 0.79: it tends to move less than the market.
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide.
Want to see everything about Bachem?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
About CHF 38.27 per share according to ATLAS (reasonable range: CHF 25.73 to CHF 56.37). With the stock at CHF 83.35, it is 118% above it.
51%: close to a coin flip. In half of the simulated outcomes, BANB.SW ends the month between CHF 79.38 and CHF 87.90.
Bachem's market capitalization is CHF 6.2B. Its price-to-earnings (P/E) ratio is 42.5: you pay CHF 42.5 for each CHF 1.00 of yearly earnings.
Yes. BANB.SW's current dividend yield is 1.05% at today's price (CHF 83.35).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy